Org.nr 917 359 725 2023 → 2024 Year-over-year analysis

3P BIOTECH HOLDING AS: årsregnskap 2024 vs 2023

Another loss-making year

approved 2025-04-22; registry 2025-05-03; journal 2025 402176

Full company analysis · All year comparisons

What changed

Comparing Årsregnskap 2024 with 2023 for 3P BIOTECH HOLDING AS. Net result -19.1k NOK → -20.6k NOK. Equity -30.5k NOK → -51.1k NOK.

On the constructive side: operating result improved; cash rose. Pressures included: net result weakened; equity eroded.

Also worth watching: thin equity buffer. All figures are taken from the published annual accounts for 3P BIOTECH HOLDING AS.

Scorecard

Operating result
-19.1k NOK -18.6k NOK
+2.7%
Net result
-19.1k NOK -20.6k NOK
-7.7%
Equity
-30.5k NOK -51.1k NOK
-67.6%
Cash
-195.5k NOK 2 578 NOK
+101.3%
Total assets
7.55m NOK 7.55m NOK
-0.1%

What improved

  • ↑

    Operating result improved

    Operating result -19.1k NOK → -18.6k NOK. Calculated

  • ↑

    Cash rose

    Bank deposits -195.5k NOK → 2 578 NOK (+101.3% YoY). Calculated

What deteriorated

  • ↓

    Net result weakened

    Net result -19.1k NOK → -20.6k NOK. Calculated

  • ↓

    Equity eroded

    Book equity -30.5k NOK → -51.1k NOK (equity ratio -0.4% → -0.7%). Calculated

Things to notice

  • ·

    Thin equity buffer

    Equity ratio is -0.7% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation